Healthequity (HQY) In a report released yesterday, David Larsen from BTIG maintained a Buy rating on Healthequity, with a price target of $130.00. The company’s shares closed last Wednesday at $94.80, ...
In a report released yesterday, David Larsen from BTIG maintained a Hold rating on P3 Health Partners (PIII – Research Report). The ...
BTIG analyst David Larsen has maintained their neutral stance on AGL stock, giving a Hold rating today. David Larsen’s rating is based ...
In a report released yesterday, David Larsen from BTIG maintained a Buy rating on Definitive Healthcare Corp (DH – Research Report), with a price target of $7.00. David Larsen’s rating is based on ...
In a report released today, David Larsen from BTIG maintained a Buy rating on Veeva Systems (VEEV – Research Report), with a price target ...
BTIG analyst David Larsen maintained a Buy rating on CryoPort (CYRX – Research Report) today and set a price target of $13.00. The ...
The year 2024 marks the 100th anniversary since the composer’s birth. Mancini, who died in 1994 at 70 from pancreatic cancer, had earned several awards during his decadeslong career, including 20 ...
She also told them that his name was Micheal, and he would be special. Micheal David Larsen was born Nov. 9, 1981 in Fayetteville, N.C. Averill, who grew up in West St. Paul, had left LarsenâÄôs ...
7d
Analyst David Larsen of BTIG maintained a Buy rating on Health Catalyst (HCAT – Research Report), retaining the price target of $13.00.
BTIG analyst David Larsen maintained a Buy rating on Consensus Cloud Solutions (CCSI – Research Report) today and set a price target of ...
In a report released yesterday, David Larsen from BTIG maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price ...
Developers David Tabak and Meyer Lebovits are seeking to build a 14-building, 270-unit development in the Brooklyn ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback